Core Insights - Stanley Druckenmiller's Duquesne Family Office made significant adjustments to its investment portfolio in Q1 2025, including complete liquidation of 37 stocks and substantial reductions in major tech holdings [1][6] - The portfolio is now heavily concentrated in healthcare and technology sectors, with notable new investments in companies like DocuSign and TSMC [1][4][7] Summary by Category Portfolio Adjustments - Duquesne Family Office completely liquidated 37 stocks, including significant positions in Skechers USA Inc and SLM Corp, which negatively impacted the portfolio by 1.94% and 1.87% respectively [5] - Major tech stocks such as Google, Amazon, and Tesla saw reduced holdings, indicating a strategic shift away from these companies [6] New Investments - The firm added 12 new stocks to its portfolio, with the largest new position being in DocuSign Inc, acquiring 1.0747 million shares valued at $87.48 million, representing 2.86% of the portfolio [3] - Other significant new investments include CCC Intelligent Solutions Holdings Inc and EQT Corp, with respective acquisitions valued at $50.52 million and $45.92 million [3] Increased Holdings - Teva Pharmaceutical Industries Ltd and TSMC were highlighted as key increased holdings, with TSMC's shares increasing by 456.93% to a total value of $99.4 million [4] - Natera Inc remains the largest holding at 15.72%, followed by Teva and Coupang Inc at 7.47% and 6.67% respectively [4] Sector Focus - The investment portfolio is concentrated in nine sectors, with healthcare and technology being the dominant areas [1][7]
德鲁肯米勒一季度:减持谷歌、亚马逊、特斯拉,买入台积电和AppLovin